人福医药：复方醋酸钠林格注射液获得药品注册证书

Core Viewpoint - Yifan Pharmaceutical has received approval from the National Medical Products Administration for the registration of Sodium Acetate Injection, indicating a significant advancement in its product portfolio and potential market opportunities [1] Group 1: Company Developments - Yifan Pharmaceutical's subsidiary, Yichang Renfu, has been granted a drug registration certificate for Sodium Acetate Injection [1] - The Sodium Acetate Injection is intended for use in replenishing extracellular fluid during conditions of reduced circulating blood volume and tissue interstitial fluid, as well as correcting metabolic acidosis [1]